Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation

被引:2
|
作者
Jiang, Yunzhong [1 ]
Zhang, Mengzhao [2 ]
Wang, Lu [1 ]
Zhang, Lu [1 ]
Ma, Minghai [1 ]
Jing, Minxuan [1 ]
Li, Jianpeng [1 ]
Song, Rundong [1 ]
Zhang, Yuanquan [1 ]
Yang, Zezhong [1 ]
Zhang, Yaodong [1 ]
Pu, Yuanchun [1 ]
Qu, Xiaowei [3 ]
Fan, Jinhai [1 ,4 ]
机构
[1] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Vasc Surg, Affiliated Hosp 1, Xian, Peoples R China
[3] Yanan Univ, Dept Geriatr, Xianyang Hosp, Xianyang, Peoples R China
[4] Minist Educ, Key Lab Environm & Genes Related Dis, Oncol Res Lab, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
Osthole; Bladder cancer; Network Pharmacology; Molecular docking; CNIDIUM-MONNIERI; WEB SERVER; THYMOQUINONE; INHIBITION; UPDATE; GENES;
D O I
10.1186/s12906-023-03938-5
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
BackgroundOsthole was traditionally used in treatment for various diseases. However, few studies had demonstrated that osthole could suppress bladder cancer cells and its mechanism was unclear. Therefore, we performed a research to explore the potential mechanism for osthole against bladder cancer.MethodsInternet web servers SwissTargetPrediction, PharmMapper, SuperPRED, and TargetNet were used to predict the Osthole targets. GeneCards and the OMIM database were used to indicate bladder cancer targets. The intersection of two target gene fragments was used to obtain the key target genes. Protein-protein interaction (PPI) analysis was performed using the Search Tool for the Retrieval of Interacting Genes (STRING) database. Furthermore, we used gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses to explore the molecular function of target genes. AutoDock software was then used to perform molecular docking of target genes,osthole and co-crystal ligand. Finally, an in vitro experiment was conducted to validate bladder cancer inhibition by osthole.ResultsOur analysis identified 369 intersection genes for osthole, the top ten target genes included MAPK1, AKT1, SRC, HRAS, HASP90AA1, PIK3R1, PTPN11, MAPK14, CREBBP, and RXRA. The GO and KEGG pathway enrichment results revealed that the PI3K-AKT pathway was closely correlated with osthole against bladder cancer. The osthole had cytotoxic effect on bladder cancer cells according to the cytotoxic assay. Additionally, osthole blocked the bladder cancer epithelial-mesenchymal transition and promoted bladder cancer cell apoptosis by inhibiting the PI3K-AKT and Janus kinase/signal transducer and activator of transcription (JAK/STAT3) pathways.ConclusionsWe found that osthole had cytotoxic effect on bladder cancer cells and inhibited invasion, migration, and epithelial-mesenchymal transition by inhibiting PI3K-AKT and JAK/STAT3 pathways in in vitro experiment. Above all, osthole might have potential significance in treatment of bladder cancer.SubjectsBioinformatics, Computational Biology, Molecular Biology.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation
    Yunzhong Jiang
    Mengzhao Zhang
    Lu Wang
    Lu Zhang
    Minghai Ma
    Minxuan Jing
    Jianpeng Li
    Rundong Song
    Yuanquan Zhang
    Zezhong Yang
    Yaodong Zhang
    Yuanchun Pu
    Xiaowei Qu
    Jinhai Fan
    BMC Complementary Medicine and Therapies, 23
  • [2] Mechanisms of wogonoside in the treatment of atherosclerosis based on network pharmacology, molecular docking, and experimental validation
    Gong, Zhaohui
    Yang, Haixin
    Gao, Li
    Liu, Yi
    Chu, Qingmin
    Luo, Chuanjin
    Kang, Liang
    Zhai, Huiqi
    Xu, Qiang
    Wu, Wei
    Li, Nan
    Li, Rong
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2025, 25 (01)
  • [3] Potential mechanisms of Shenmai injection against POCD based on network pharmacology and molecular docking
    Yi, Honggang
    Zhang, Mengdie
    Miao, Jiang
    Mu, Lvfan
    Hu, Congli
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (08) : 931 - 942
  • [4] Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation
    Tan, Xin
    Xian, Wei
    Li, Xiaorong
    Chen, Yongfeng
    Geng, Jiayi
    Wang, Qiyi
    Gao, Qin
    Tang, Bi
    Wang, Hongju
    Kang, Pinfang
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation
    Xin Tan
    Wei Xian
    Xiaorong Li
    Yongfeng Chen
    Jiayi Geng
    Qiyi Wang
    Qin Gao
    Bi Tang
    Hongju Wang
    Pinfang Kang
    Scientific Reports, 12
  • [6] Integrated Network Pharmacology, Molecular Docking, and Experimental Validation to Explore Potential Mechanisms of Sinomenine in the Treatment of Osteoarthritis
    Wang, Shaojun
    Lai, Fanglin
    Xiang, Ting
    Xu, Yan
    NATURAL PRODUCT COMMUNICATIONS, 2024, 19 (07)
  • [7] Network Pharmacology and Molecular Docking Validation to Reveal the Pharmacological Mechanisms of Kangai Injection against Colorectal Cancer
    Zheng, Bo-Bo
    Wang, Quan
    Yue, Yumin
    Li, Jiang
    Li, Xiao-Jun
    Wang, Xin
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [8] Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking
    Zhu, Ning
    Huang, Bingwu
    Zhu, Liuyan
    Wang, Yi
    JOURNAL OF DIABETES RESEARCH, 2021, 2021
  • [9] Mechanisms of action of Sappan lignum for prostate cancer treatment: network pharmacology, molecular docking and experimental validation
    Li, Wenna
    Jiang, Honglin
    Zhang, Weina
    Sun, Qiuyue
    Zhang, Qiaoli
    Xu, Jingnan
    Huang, Jinchang
    Wan, Yuxiang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] The potential mechanism of ursolic acid in the treatment of bladder cancer based on network pharmacology and molecular docking
    Huang, Xiao-Long
    Sun, Yan
    Wen, Peng
    Pan, Jun-Cheng
    He, Wei-Yang
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (03)